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Different body sites—including the mouth, hair, nose, ears, vagina, and skin—have their 
own unique microbiomes, communities of microbes that perform innumerable services for 
their human hosts. We are now seeing that our microbiomes also modify environmental 
exposures in ways not previously considered by environmental health scientists.
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he agents we now know as 
bacteria have been known 
for  centuries  to  play  a 
key role in certain kinds of illnesses 
and ailments. But aside from infec­
tious diseases, the communities of 
microbes we carry in specific parts of 
our bodies—our microbiomes—are a 
relatively new topic in human health. 
Now this field of study has taken an 
evolutionary leap forward with new 
research showing human microbiomes 
may play a far greater role in environ­
mental health than ever imagined. 
The excitement around this field 
was obvious at a National Academy 
of Sciences (NAS) workshop on the 
interplay of the microbiomes, environ­
mental agents, and human health 
held 27–28 April 2011,
1 where talks 
by researchers working in this area 
inspired numerous “eureka!” moments. 
New findings about the ways in which 
human microbiomes transform arsenic 
and mercury—two of our most preva­
lent and well­defined external human 
health hazards—suggest the role of 
commensal bacteria may equal or 
exceed that of genetic polymorphisms 
that regulate metal transformations 
within the body, says Ellen Silbergeld, 
a professor of environmental health sci­
ences at the Johns Hopkins University 
Bloomberg School of Public Health. 
The implications of these new 
insights are staggering. Environmental 
health scientists may need to expand 
the toxicokinetics of metals and other 
environmental agents, as well as associ­
ated biomarkers, to include the micro­
bial component. “This is a huge thing 
that has never been thought of before 
in environmental health sciences,” 
Silbergeld told workshop attendees.Focus  | A Study in Balance
Emerging findings also demand a re­
examination of what it means to be exposed 
to environmental agents, Silbergeld says. To 
a toxicologist, she explains, a contaminant is 
only “in the body” once it has crossed from the 
external environment into circulating blood, 
or a cell, or an organ. But new findings suggest 
biologically relevant transformations may take 
place prior to absorption, when contaminants 
interact with the microbiome in the mouth, 
intestines, or other tissues. Because of the meta­
bolic processes mediated by microbiomes, a 
great deal of what toxicologists attribute to 
human metabolism—such as methylation of 
arsenic—may actually take place at least in part 
before contaminants cross into the internal 
environment of our bodies.
Our Microbiomes: Works in 
Progress
All body sites—including the mouth, hair, 
nose, ears, vagina, lungs, and skin—have 
their own unique microbiomes. A person’s 
microbiomes are at least partly transferred 
at birth from the mother; scientists have 
documented differences in the microbiomes 
of infants born vaginally and by caesarean 
section.
2 Microbiomes go through several 
transitions during the first years of life, then 
remain relatively constant throughout much 
of a person’s life until about age 65.
3 
In adulthood the composition of micro­
biomes is influenced not only by host genetics 
but also by the environment, diet, and other 
factors.
4,5,6,7 If the composition of a microbiome 
changes, the range of services it provides its 
human host also may shift. Lita Proctor, coor­
dinator for the National Institutes of Health’s 
Human Microbiome Project,
8 says the key bac­
terial organ is the intestinal microbiome; vari­
ability in this microbiome may be an important 
source of individual variability in human health 
and disease. 
In fact, Jeremy Nicholson of Imperial 
College London recently published a land­
mark article documenting that the intestinal 
microbiome played a key role in promoting 
the expression of cytochrome P450 enzymes, 
which break down xenobiotic substances such 
as toxic chemicals.
9 Nicholson’s team showed 
that when “germ­free” mice born and raised in 
sterile environments were colonized with intes­
tinal microbes, their expression of cytochrome 
P450s increased. In addition to indicating 
the intestinal microbiome enhances the host’s 
metabolic capacity for processing nutrients 
and drugs, the authors speculate “microbiota 
manipulation” may someday help improve 
drug delivery in personalized health care. 
The human intestinal microbiome appears 
to fall into one of three distinct enterotypes, or 
bacterial profiles, first defined in 2011 by the 
European Commission’s Metagenomics of the 
Human Intestinal Tract consortium.
10 Analy­
sis of 39 intestinal microbiome metagenomes 
of adults from four European countries, the 
United States, and Japan indicates individuals 
have one of these three enterotypes, which are 
characterized by higher proportions of Bacteroi-
des, Prevotella, or Ruminococcus species.
11 The 
enterotypes cross international and continental 
borders, as well as race, ethnicity, sex, and age. 
It is too soon to know how the three entero­
types differ in their ability to process environ­
mental agents. 
Scientists have long known that human 
intestinal bacteria synthesize important sub­
stances such as vitamin K. New evidence indi­
cates our microbiomes are, in fact, “chemi­
cal factories” that produce a complex set of 
molecules, including druglike compounds and 
peptides that act as neurotransmitters, says 
Michael Fischbach, an assistant professor at the 
University of California, San Francisco, School 
of Pharmacy. Among other things, Fischbach is 
studying whether some of the compounds pro­
duced by the intestinal microbiome bind the 
aryl hydrocarbon receptor. This is potentially 
important because this receptor’s activation can 
lead to changes in gene expression that adverse­
ly affect many human cellular processes.
Other conversions performed by gut 
microbes can be beneficial, such as metabo­
lization of phytoestrogen precursors from a 
wide variety of plants into more biolog  ically 
active components associated with certain 
health benefits. For example, isoxanthohumol 
is a phytoestrogen precursor occurring in hops 
that microbes can convert into 8­prenylnar­
ingenin, which has known anti­inflammatory 
and cardio  protective properties.
12 Recent work 
has documented variability in the ability of 
individuals to convert isoxanthohumol into 
8­prenylnaringenin, a phenomenon Tom Van 
de Wiele, an assistant professor in the Labora­
tory of Microbial Ecology and Technology at 
Ghent University, Belgium, says may be due in 
part to differences in the composition of their 
intestinal microbiomes.
13
One family of microbes may biotransform 
contaminants into a new form, whereas another 
group may transform that new form back into 
its previous form or into something completely 
new with completely different biological activ­
ity, according to Van de Wiele. For example, 
he points out the polycyclic aromatic hydro­
carbons (PAHs) naphthalene, phenanthrene, 
pyrene, and benzo[a]pyrene do not typically 
exhibit estrogenic properties in the body. How­
ever, he conducted experiments that showed 
incubating these four compounds, particularly 
the latter two, with bacteria from the human 
colon resulted in the formation of compounds 
with estrogen­like activity.
14 “The number of 
chemical conversions [in bacteria] is tremen­
dously large. In fact, the metabolic potency is 
thought to exceed even that of the liver,” Van 
de Wiele says.
The implications of all this are dramatic 
when one considers how little geography mat­
ters to bacteria. “People who haven’t worked 
with bacteria that much tend to under­
estimate what they can do,” Silbergeld says. 
In 2007 researchers at the U.S. Geological 
Survey published research documenting both 
the global movement of dust across conti­
nents and oceans
15 and the fact that bacteria 
can hitch transcontinental rides on these dirt 
particles.
16 Microbes can also just as easily 
travel by plane, as documented in the case of 
antibiotic­resistant bacteria that traveled from 
hospitals in India to the United Kingdom.
17 
Microbiomes and Metals
Scientists have known for decades that certain 
bacteria in the environment alter metal com­
pounds in ways that make the metals more 
bioaccessible to humans. The evidence that 
certain microbes in the human gut also can 
transform metals has been steadily accumu­
lating, although only recently have environ­
mental health scientists begun to grasp the 
implications. 
One of the catalysts for this shift in think­
ing was the 2010 publication of a study in 
which Van de Wiele and his team used a 
“human gastrointestinal simulator” to analyze 
how human intestinal bacteria metabolize inor­
ganic arsenic from contaminated soils. Differ­
ent arsenic species vary widely in their toxicity, 
so it matters a great deal how arsenic is trans­
formed within the body. Van de Wiele’s team 
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argaret McFall-Ngai, a comparative animal 
biologist at the University of Wisconsin  –Madison, 
says recent evidence from evolutionary biology 
suggests the evolution of many human genes was likely 
driven by interaction with the microbiome.
33 Tom Van de 
Wiele of Ghent University, Belgium, adds, “Many of these 
genes were ‘invented’ in a time when the first higher 
organisms developed and were forced to interact with the 
omnipresent microorganisms.”Focus  | A Study in Balance
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showed the bacteria transformed inorganic 
arsenic to methylated arsenicals and thioarsen­
icals, including the first known observation 
of metabolically derived monomethylmono­
thioarsonic acid, whose toxicokinetic proper­
ties are unclear.
18 When considered together 
with other recent research, these results sug­
gest interindividual differences among human 
microbiomes may make a significant difference 
in the toxicity of metals and their contribu­
tions to chronic diseases associated with these 
metals, such as cardiovascular disease and type 
2 diabetes mellitus.
Scientists agree that re­examining environ­
mental exposures through the lens of the 
microbiome is likely to yield more insights 
into bacterial impacts. For instance, the ability 
of intestinal bacteria to demethylate methyl­
mercury
19 is important because the process 
could result in unexpected exposure to toxic 
inorganic mercury. “It is possible that [many 
people] may be internally exposed to inorganic 
mercury much more than we have ever calcu­
lated because of demethylation of the mercury 
we take in through fish consumption,” Sil­
bergeld says. 
Many people worldwide are already reg­
ularly exposed to inorganic mercury during 
gold­mining operations.
20 A major percentage 
of Americans also may be exposed to high 
levels of the element via silver amalgam dental 
fillings in their teeth, according to an anal­
ysis by Mark Richardson, a risk assessment 
specialist at consulting firm SNC Lavalin.
21,22 
On the basis of an analysis he presented at a 
14–15 December 2010 meeting of the U.S. 
Food and Drug Administration Dental Prod­
ucts Panel, Richardson estimated that one­
quarter to one­third of Americans may be regu­
larly exposed to concentrations of inorganic 
mercury from amalgam fillings that exceed 
recommended exposure limits set by the U.S. 
Environmental Protection Agency (EPA) and 
the California EPA. 
Thousands of studies have shown that 
mercury affects many metabolic processes and 
organ systems in humans and experimental 
animals. Silbergeld says research by her labora­
tory and others indicates inorganic mercury 
can also impact the mucosal immune system, 
for instance by increasing the production of 
proinflammatory cytokines and serum levels 
of biomarkers of immune alteration related to 
autoimmunity.
 23,24,25,26 On top of that, contact 
between mucosal cells of the immune system 
and the intestinal microbiome means each will 
affect the other, she says. To Silbergeld, this 
suggests interactions between environmental 
contaminants and the microbiome may be 
bidirectional. 
The implications also further strengthen the 
argument for including immunology and infec­
tious disease under the umbrella of environ­
mental health.
27 Linda Birnbaum, director of 
the National Institute of the Environ  mental 
Health Sciences (NIEHS), says the institute’s 
research is repeatedly uncovering new interac­
tions between the immune system and diseases 
she says clearly have environmental compo­
nents, such as autism and breast cancer. “We 
know there are numerous and complex rela­
tionships between the microbiome and our 
immune system,” Birnbaum says.
Metals and Antibiotic 
Resistance
One reason microbes are so successful on 
this planet is that they don’t limit their gene 
exchange to reproduction. Instead, Proctor 
says, “They promiscuously share genes across 
all kinds of habitats and under all kinds of 
conditions.” They do this by sharing snippets 
of DNA known as plasmids, a process known 
as horizontal gene transfer that has nothing to 
do with reproduction.
28 “Microbes do it very, 
very well, and they do it a lot,” Proctor says. 
Plasmid sharing is one way bacteria develop 
resistance not only to antibiotics but to any 
agent that threatens their survival, including 
metals. In situations where intestinal bacte­
ria are continuously exposed to a metal such 
as mercury, those bacteria with the genetic 
machinery that enables them to tolerate the 
metal are more likely to survive and repro­
duce. Anne Summers, a microbiologist at the 
University of Georgia, explains, “In the high­
impact environments there are more complex 
plasmids, but the underlying machinery for 
generating that complexity has been enabling 
bacterial evolution for eons.” She says humans 
have generated unprecedented environments 
with high concentrations of antibiotics and 
metals, especially mercury, inside our bodies. 
Summers says bacterial exposure to metals 
such as mercury can contribute to antimicro­
bial resistance because many transferrable plas­
mids carry genes for multiple types resistance. 
In other words, in the process of developing 
metal resistance, a bacterium may also become 
resistant to an antibiotic it hasn’t even encoun­
tered. This is important because the result of 
our collective microbiomes’ gene transfers may 
not always be as good for us as they are for our 
microbiomes, says Les Dethlefsen, a staff scien­
tist at Stanford University. As Silbergeld puts it: 
“We may exist at the pleasure of the microbes.”
In studies conducted using monkeys with 
amalgam fillings, Summers demonstrated that 
exposure of the primates’ oral and intestinal 
microbiomes to inorganic mercury from their 
teeth was associated with a large increase in 
bacteria that were resistant both to mercury and 
to multiple antibiotics.
29 Similarly, research­
ers at the Technical University of Denmark 
studying Staphylococcus aureus from Danish 
swine reported that the plasmid containing a 
gene for methicillin resistance also contained a 
gene that conferred resistance to zinc and cad­
mium.
30 The authors point out that zinc oxide 
is widely used to prevent diarrheal diseases 
in livestock, and they say that both human 
and animal exposures to metals such as zinc 
and cadmium may perpetuate the spread of 
methicillin­resistant S. aureus.  
Indeed, similar results are turning up in 
studies in human populations, such as an inves­
tigation by a team of researchers led by David 
Skurnik, who is affiliated with the Université 
Paris­Diderot and Harvard Medical School.
31 
The study involved two groups: French subjects 
consisting of pig farmers and bank insurance 
workers, and French Guyanan subjects con­
sisting of city­dwelling French expatriates and 
members of the indigenous Wayampi tribe 
living in an isolated area. The Wayampi were 
heavily exposed to mercury used in artisanal 
gold mining, whereas all the other subjects lived 
in environments with low levels of mercury. 
The researchers reported finding mercury­
resistant Escherichia coli significantly more 
frequently in the pig farmers than in the 
bank insurance workers; the farmers also had 
higher carriage rates of antibiotic­resistant 
E. coli. In parallel, the scientists found the 
Wayampi participants had greater numbers of 
antibiotic­resistant E. coli than the expatriates, 
even though the tribe members used fewer 
antibiotics.
31
Building New Knowledge
Steve Rappaport, a professor of environ­
mental health sciences at the University 
G
ary Huffnagle, a professor in the Department of 
Microbiology and Immunology at the University of 
Michigan, is studying microbiomes of the lungs—a 
relatively new area of study even for microbiomes, because lungs 
were long thought to be a relatively sterile environment. “When 
we look at [the lung microbiome] in terms of its composition 
at a genus level, the first thing you will see is that there are 
some individuals that have . . . very limited diversity in their lung 
microbiome, and others that have quite a bit of diversity,”
34 
Huffnagle told participants at the April NAS meeting. Collections of communities
Each person is host to some 100 trillion microbes,  
predominantly bacteria. These microbes live throughout  
the body in communities called microbiomes.
The Human Microbiome Project (HMP) of the National 
Institutes of Health has set four goals to better understand 
the role of microbiomes in human health: 1) determine 
whether individuals share a core human microbiome, 2) 
understand whether changes in microbiomes correlate 
with changes in health, 3) develop technological and 
bioinformatic tools to support these goals, and 4) address 
the ethical, legal and social implications raised by human 
microbiome research. 
Human Microbiomes
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 Mouth
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Gastrointestinal  
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Skin
Human form: Shutterstock.com; figure: adapted from Costello et al. (2009)
It’s personal
Microbiome composition can vary widely among 
individ  uals and between different sites on a person’s 
body. In adulthood, the composition of any given 
microbiome is influenced not only by host genetics but 
also by the environ  ment, diet, and other factors.
The intestinal microbiome is thought to be a key player 
in health. Human intestinal microbiomes appear to have 
one of three distinct enterotypes, or bacterial profiles, 
characterized by prominence of a certain genus.
11 
Our microbiomes play key roles in immunity and 
digestion. New data suggest they also mediate metabolic 
processes such as methylation of potentially toxic metals. 
Interindividual differences in the composition of our 
microbiomes may be an important reason why people 
vary in their response to environmental stressors.
▲ A metric known as UniFrac distance reflects the similarity of phyla 
present in a given sample, with a shorter distance indicating greater 
similarity. A study of the bacterial diversity of 27 body sites sampled 
over time in healthy adults revealed that individuals’ mouth and 
intestinal (gut) microbiomes varied the least over time whereas skin, 
hair, nostril, and external auditory canal (EAC) microbiomes varied the 
most. Areas of the skin with the greatest species diversity tended to be 
the forearm, palm, index finger, back of the knee, and sole of the foot. 
The mouth and intestinal microbiomes tended to diverge markedly 
from the other microbiomes in their composition.
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Lifetime achievement
Once established, microbiomes remain relatively constant 
throughout a person’s life until about age 65.
The exposome
Microbiomes form one component of a new concept 
known as the “exposome,” or the measure of all of 
an individual’s exposures over his or her lifetime and 
how those exposures affect disease risk. In the words 
of Stephen Rappaport and Martyn Smith, we should 
“consider the ‘environment’ as the body’s internal 
chemical environment and ‘exposures’ as the amounts of 
biologically active chemicals in this internal environment. 
Under this view, exposures are not restricted to chemicals 
(toxicants) entering the body from air, water, or food, 
for example, but also include chemicals produced by 
inflammation, oxidative stress, lipid peroxidation, 
infections, gut flora [microbiomes], and other natural 
processes.”
32
Microbiomes and resistance
Commensal bacteria can develop resistance to anti­
biotics, metals, and other environmental stressors. 
One way they do this is by exchanging fragments of 
DNA called plasmids (they can also transfer resistance 
genes packaged in viruses or acquire segments of 
DNA released from dead cells). Plasmids can carry 
different genes conferring resistance to multiple 
agents, which means bacteria can become resistant 
to stressors they haven’t even encountered. ▼
Human form: Shutterstock.com; figure: adapted from Costello et al. (2009)
Photographs: istockphoto.com; resistance diagram: Bryson Biomedical Illustrations, Inc.; 
figure: adapted from Claesson et al. (2010)
Gene goes to  
plasmid or  
to chromosome
Transfer by  
viral delivery
Transfer of 
free DNA from  
dead bacterium
Plasmid transfer 
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(in red)
▲ Analysis of the core intestinal microbes of elderly 
subjects compared with younger adults showed 
differences between the two age groups in proportions 
of phyla, genera, and clusters of highly diverse 
Clostridium species.
3 Better understanding of the unique 
characteristics of the elderly intestinal microbiome may 
lead to recommendations for dietary interventions to 
improve elders’ health.
▲ An infant born vaginally is initially 
colonized with its mother’s birth canal 
microbiome during birth, whereas an infant 
delivered via cesarean section carries more 
of its mother’s skin microbiome.
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of California, Berkeley, says the environ­
mental health community is now beginning 
to embrace a new concept that goes beyond 
the microbiome. This new concept is the 
“exposome,” which the National Institute for 
Occupational Safety and Health defines as 
the measure of all of an individual’s exposures 
over his or her lifetime and how those expo­
sures affect disease risk. Rappaport says the 
environmental exposures that affect human 
health may include “all kinds of endogenous 
processes that have so far escaped our inter­
est in finding the environmental causes of 
disease”—including the microbiome and 
inflammatory processes.
32 
The concept of the exposome blurs the 
distinction between exposure and response. 
“For years we talked about biomarkers, and we 
differentiated between biomarkers of exposure 
and biomarkers of response,” Rappaport says. 
“But when you really start drilling down into 
that concept of a biomarker, it can become dif­
ficult to make that differentiation.” 
A recent example of this blurriness is a dis­
covery by a group led by Stanley Hazen of the 
Cleveland Clinic’s Department of Cell Biology. 
The researchers reported identifying trimethyl­
amine N­oxide (TMAO) as a biomarker that 
is highly predictive of cardio  vascular disease 
in Americans, and they provided evidence the 
intestinal microbiome plays a role in generating 
TMAO.
33 The process begins with choline, an 
essential micronutrient, which intestinal bacte­
rial transform catabolically to trimethylamine 
(TMA). TMA can be absorbed into the blood, 
where it is transported to the liver and metabo­
lized to produce TMAO. But it is still unclear 
whether TMAO is a biomarker of the presence 
of choline, a particular intestinal bacterium, 
metabolism of TMA in the liver, factors related 
to arterial inflammation, or some combination 
of all of these, Rappaport says.
From  a  regulatory  perspective,  Rita 
Schoeny, senior science advisor for the EPA 
Office of Water, says revelations at the April 
NAS conference about the potential role of the 
microbiomes in disease risk raise many ques­
tions. For instance, EPA regulations for arsenic, 
and to some extent for mercury, are based on 
what scientists understand to be “a lovely pro­
gression of reduction and methylation with 
more reduction and methylation”—none of 
which, she says, considers microbial metabo­
lism. Schoeny says the EPA Office of Water 
regulates microbes as something to be avoid­
ed, particularly in drinking water, under the 
assumption that the “only good bug is a nonex­
istent bug”; the microbiome is currently not on 
the agency’s radar in terms of policy making.
Vincent Cogliano, director of the EPA’s 
Integrated Risk Information System, told par­
ticipants at the April meeting he is concerned 
about the absence of microbiome information 
in the interpretation of toxicity testing results. 
“Regulatory agencies are putting a lot of effort 
into understanding the sequence of mecha­
nistic events that lead to disease. It looks like 
we have been ignoring a big number of these 
events that could be there,” he said. He likened 
the current approach to trying to write a novel 
without any prepositions. “You can put some 
coherent thoughts together,” he said, “but you 
cannot tell a story that is very complex or very 
interesting.”
How might our growing awareness of 
microbiomes inform public health policy? 
Bruce Fowler, assistant director for science in 
the Division of Toxicology and Environmental 
Medicine at the Agency for Toxic Substances 
and Disease Registry, says it comes down to 
translational risk assessment. “We recognize that 
there are individuals within the population who 
are especially sensitive to chemicals as a result 
of age, life stage, diet, nutrition, what have 
you,” Fowler said at the April meeting. “I think 
the microbiome just quite simply hasn’t been 
plugged into this, and I think it should be.”
Lisa Helbling Chadwick, the NIEHS 
liaison for the Human Microbiome Project, 
says the institute is increasing its focus on the 
impact of microbiomes on toxicology. “One 
thing we are really interested in at NIEHS 
is understanding how individuals respond 
differently to exposures, what makes one per­
son more susceptible to adverse health out­
comes from an exposure than another,” she 
says. “Genetics only partially explains this.” 
Birnbaum adds, “We recognize the enormous 
implications of the growing awareness of inter­
actions between chemical exposures and the 
microbiome, and we have begun exploring 
these issues.” 
Kellyn S. Betts has written about environmental contami­
nants, hazards, and technology for solving environmental 
problems for publications including EHP and Environmental 
Science & Technology for more than a dozen years.
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